Concordance of measures of left-ventricular hypertrophy in pediatric hypertension

D Mirchandani1, J Bhatia, D Leisman

  • 1Department of Pediatrics, Cohen Children's Medical Center of New York, North Shore-LIJ Health System, New Hyde Park, NY, USA.

Pediatric Cardiology
|November 21, 2013
PubMed

Insights

Pediatric hypertension diagnosis lacks consensus for left-ventricular (LV) hypertrophy (LVH). Echocardiogram findings show poor agreement between wall-thickness z-score and LV mass index (LVMI) criteria, impacting treatment decisions.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Imaging
  • Hypertension Management

Background:

  • The American Academy of Pediatrics (AAP) recommends echocardiography for pediatric hypertension to detect left-ventricular hypertrophy (LVH).
  • LVH is an indicator for initiating or intensifying antihypertensive therapy in children.
  • Current diagnostic methods for pediatric LVH lack consensus, with varying reliance on wall-thickness z-scores versus LV mass index (LVMI).

Purpose of the Study:

  • To determine the concordance between LVH diagnosis using LV wall-thickness z-scores and LVMI criteria in pediatric hypertension.
  • To evaluate agreement between LVH diagnosis by wall-thickness z-score and LVMI(2.7) > 95th percentile.
  • To assess agreement between LVH diagnosis by wall-thickness z-score and LVMI(2.7) ≥ 51 g/m(2.7).

Main Methods:

  • Retrospective chart review of echocardiogram reports for children with hypertension (2009-2012).
  • LVH assessment recorded based on three criteria: LV wall-thickness z-score > 2.00, LVMI(2.7) > 95th percentile, and LVMI(2.7) ≥ 51 g/m(2.7).
  • Cohen's kappa statistic used to measure agreement between wall-thickness z-score and LVMI(2.7) criteria.

Main Results:

  • LVH was diagnosed in 20% by wall-thickness z-score and 47% by LVMI(2.7) > 95th percentile.
  • Agreement between wall-thickness z-score and LVMI(2.7) > 95th percentile was 71% (kappa 0.4).
  • Agreement between wall-thickness z-score and LVMI(2.7) ≥ 51 g/m(2.7) was 79% (kappa 0.37).

Conclusions:

  • There is poor concordance between echocardiogram-based LVH diagnosis using wall-thickness z-scores and LVMI(2.7) criteria in pediatric hypertension.
  • Discrepancies in LVH diagnosis can affect antihypertensive therapy decisions.
  • Establishing a consensus diagnostic method for pediatric LVH is crucial due to high rates of cardiovascular complications.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
891
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K